Study of plasmid-mediated extended-spectrum β-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a north indian tertiary-care hospital

Diabetes Technology and Therapeutics

Volumn 14, Issue 4, 2012, Pages 315-324

  Zubair, Mohammad ^a   Malik, Abida ^a   Ahmad, Jamal ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; GATIFLOXACIN; GLYCOPEPTIDE; IMIPENEM; LINCOSAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROLIDE; METRONIDAZOLE; MONOBACTAM; OFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; TRIACYLGLYCEROL;

ADULT; ADVERSE OUTCOME; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLA GENE; COMORBIDITY; CONTROLLED STUDY; DIABETIC FOOT; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENE FREQUENCY; HUMAN; INDIA; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; RISK FACTOR; TERTIARY HEALTH CARE;

AMPUTATION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DIABETIC FOOT; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GANGRENE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84859355147     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0197     Document Type: Article

References (51)

1. Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217-228. (Pubitemid 40095873)
2. Rao S, Saltzman C, Yack HJ: Segmental foot mobility in individuals with and without diabetes and neuropathy. Clin Biomech 2007;22:464-471. (Pubitemid 46509684)
3. Zubair M, Malik A, Ahmad J: Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India. Foot 2011;21:6-14.
4. Roghmann MC, Siddiqui A, Plaisance K, Standiford H: MRSA colonisation and the risk of MRSA bacteraemia in hospitalised patients with chronic ulcers. J Hosp Infect 2001;47:98-103. (Pubitemid 32181722)
5. Amstrong DG, Liswood PJ, Todd WF: Prevalence of mixed infections in the diabetic pedal wound: A retrospective review of 112 infections. J Am Podiatr Med Assoc 1995;85: 533-537.
6. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry RA: Clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006;29:1727-1732. (Pubitemid 44156621)
7. Zubair M, Malik A, Ahmad J, Shahid M: Prevalence of blaCTX-M in diabetic foot infections: A hospital based study [abstract]. Endocr Rev 2011;32(Suppl):P1-546.
8. Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, Agarwal G, Agarwal A, Mishra SK: Changing microbiological profile of pathogenic bacteria in diabetic foot infection: time for a rethink on which empirical therapy to choose? Diabetologia 2011;54:58-64.
9. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, Grimaldi A: Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 2004;21:710-715. (Pubitemid 38916215)
10. Jacoby GA, Munoz Price LS: The new b lactamases. N Engl J Med 2005;355:380-391.
11. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO: Extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32: 1162-1171. (Pubitemid 32390110)
12. Collee JG, Duguid JP, Fraser AG, Marmion BP, Simmons A: Laboratory strategy in the diagnosis of infective syndrome. In: Mackie and McCartney Practical Microbiology, 14th ed. London: Churchill Livingstone, 1996: 53-94.
13. Collee JG, Marr W: Culture of bacteria. In: Mackie and McCartney Practical Microbiology, 14th ed. London: Churchill Livingstone, 1996:113-130.
14. Coollee JG, Brown R, Poxton IR: Clostridia of wound infection. In: Mackie & McCartney Practical Medical Microbiology, 14th ed. London: Churchill Livingstone, 1996: 521-536.
15. Brown R, Coollee J.G, Poxton IR: Bacteroides, Fusobacterium and other gram negative anaerobic; anaerobic cocci; identification of anaerobes. In: Mackie & McCartney Practical Medical Microbiology, 14th ed. London: Churchill Livingstone, 1996:501-520.
16. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
17. Peterson DL, Bonomo RA: Extended spectrum beta lactamases: A clinical update. Clin Microbiol Rev 2005;18: 657-686.
18. Shahid M, Ensor VM, Hawkey PM: Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in a community in North-India. World J Microbiol Biotech 2009;25:1439-1446.
19. Shahid M, Malik A, Adil M, Jahan N, Malik R: Comparison of beta-lactamase genes in clinical and food bacterial isolates in India. J Infect Dev Ctries 2009;3:593-598.
20. Gerding DN: Foot infections in diabetic patients: The risk of anaerobes. Clin Infect Dis 1995;20(Suppl):S283-S288.
21. Dang CN, Prasad YD, Boulton AJ, Jude EB: Methicillinresistant Staphylococcus aureus in the diabetic foot clinic: A worsening problem. Diabet Med 2003;20:159-161. (Pubitemid 36269659)
22. Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abramson MA: Bacteriology of moderate to severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007;45:2819-2828. (Pubitemid 47417321)
23. Lipsky BA, Pecoraro RE, Wheat LJ: The diabetic foot: soft tissue and bone infection. Infect Dis Clin North Am 1990;4:409-32.
24. Grayson ML: Diabetic foot infections: antimicrobial therapy. Infect Dis Clin North Am 1995;9:143-161.
25. Joseph WS, Axler DA: Microbiology and antimicrobial therapy of diabetic foot infections. Clin Podiatr Med Surg 1990;7:467-481. (Pubitemid 20277448)
26. Shankar EM, Mohan V, Premalatha G, Srinivasan RS, Usha AR: Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med 2006;16:567-570.
27. Livermore DM: b-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-584.
28. Raja NS: Microbiology of diabetic foot infections in a teaching hospital in Malaysia: A retrospective study of 194 cases. J Microbiol Immunol Infect 2007;40:39-44. (Pubitemid 47047136)
29. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A: Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: A single centre Indian experience. J Infect 2004;48:96-101. (Pubitemid 38072208)
30. Scher K, Steele F: The septic foot in patients with diabetes. Surgery 1988;104:661-666.
31. Louie TJ, Bartlett JG, Tally FP, Gorbach SL: Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976;85:461-463.
32. Goldstein EJ, Citron DM, Nesbit CA: Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 1996;19:638-641. (Pubitemid 26181113)
33. Viswanathan V, Jasmine JJ, Snehalatha C, Ramachandran A: Prevalence of pathogens in diabetic foot infection in South India type 2 diabetic patients. J Assoc Physicians India 2002;50:1013-1016.
34. Lipsky BA, Berendt AR: Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev 2000;16(Suppl 1):42-46.
35. Hart CA, Kariuki S: Antimicrobial resistance in developing countries. BMJ 1998;317:647-650. (Pubitemid 28403493)
36. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, Sader HS, Kugler K, Beach M: Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999;29:595-607. (Pubitemid 29439960)
37. Cars O, Mö lstad S, Melander A: Variation in antibiotic use in the European Union. Lancet 2001;357:1851-1853. (Pubitemid 32539121)
38. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for b-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39: 1211-1233.
39. Mathur P, Tatman A, Das B, Dhavan B: Prevalence of ESBL gram negative bacteria in a tertiary care hospital. Indian J Med Microbiol 2002;115:153-157.
40. Babypadmini S, Appalaraju B: Extended-spectrum b-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-174. (Pubitemid 39206740)
41. Armstrong DG, Lipsky BA: Advances in the treatment of diabetic foot Infections. Diabetes Technol Ther 2004;6:167-177. (Pubitemid 38445742)
42. Shobha KL, Ramachandra L, Rao G, Majumder S, Rao SP: Extended spectrum beta-lactamases (ESBL) in gram negative bacilli at a tertiary care hospital. J Clin Diagnostic Res 2009; 3:1307-1312.
43. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L: Prevalence and molecular epidemiology of CTX-M extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003;47:3724-3732. (Pubitemid 37484979)
44. Bonnet R: Growing group of extended-spectrum betalactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14. (Pubitemid 38040170)
45. Rodríguez-Banëo J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, Pascual A: Clinical and molecular epidemiology of extended-spectrum b-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006; 42:37-45.
46. Sekar B, Shwetha R, Arunagiri K, Menaka K, Lalitha P, Aparna V, Shankar AK, Raja P, Suresh G: Detection and characterization of blaCTX-M gene by PCR-RFLP analysis among third generation cephalosporin resistant Gram negative isolates [abstract OB-17]. In: Proceedings of MICROCON 2006. XXX National Congress of Indian Association of Medical Microbiologists. Nagpur, India: Government Medical College, 2006:27.
47. Goyal A, Prasad KN, Gupta S, Ghoshal U, Ayyagari A: Extended spectrum beta-lactamases in E. coli and K. pneumoniae: prevalence and associated risk factors [abstract BO-13]. In: Proceedings of MICROCON 2007. XXXI National Congress of Indian Association of Medical Microbiologists. Mangalore, India: Kasturba Medical College, 2007:58.
48. Gold HS, Mollering RC: Antimicrobial drug resistance. N Engl J Med 1996;335:1445-1453.
49. Dinh TL, Veves A: The diabetic foot. In: Defronzo RA, Ferrannini E, Keen H, Zimmet P, eds. International Textbook of Diabetes Mellitus, 3rd ed. Chichester, UK: John Wiley & Sons, Ltd., 2004:1315-1332.
50. Calvet MH, Yoshikawa TT: Infections in diabetes. Infect Dis Clin North Am 2001;15:407-418.
51. Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJ, Schaper NC: The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 2001;18:229-234. (Pubitemid 32397862)